• English
    • Ελληνικά
    • Deutsch
    • français
    • italiano
    • español
  • français 
    • English
    • Ελληνικά
    • Deutsch
    • français
    • italiano
    • español
  • Ouvrir une session
Voir le document 
  •   Accueil de DSpace
  • Επιστημονικές Δημοσιεύσεις Μελών ΠΘ (ΕΔΠΘ)
  • Δημοσιεύσεις σε περιοδικά, συνέδρια, κεφάλαια βιβλίων κλπ.
  • Voir le document
  •   Accueil de DSpace
  • Επιστημονικές Δημοσιεύσεις Μελών ΠΘ (ΕΔΠΘ)
  • Δημοσιεύσεις σε περιοδικά, συνέδρια, κεφάλαια βιβλίων κλπ.
  • Voir le document
JavaScript is disabled for your browser. Some features of this site may not work without it.
Tout DSpace
  • Communautés & Collections
  • Par date de publication
  • Auteurs
  • Titres
  • Sujets

Risk in atrial fibrillation: left atrial function matters

Thumbnail
Auteur
Triposkiadis F., Xanthopoulos A., Parissis J.
Date
2019
Language
en
DOI
10.1002/ejhf.1637
Sujet
angiotensin receptor antagonist
blood clotting factor 10a
dipeptidyl carboxypeptidase inhibitor
ablation therapy
all cause mortality
anticoagulant therapy
atrial fibrillation
blood clot lysis
cardiac resynchronization therapy
cardiovascular mortality
cardiovascular parameters
cardiovascular risk
disease association
dyspnea
Editorial
heart atrium remodeling
heart failure
heart function
heart infarction
heart left atrium
heart left atrium emptying fraction
heart left atrium expansion index
heart left atrium volume index
heart left ventricle function
hospitalization
human
hypertension
morphology
mortality rate
priority journal
transthoracic echocardiography
atrial fibrillation
cardioversion
heart atrium
heart atrium function
heart failure
Atrial Fibrillation
Atrial Function, Left
Electric Countershock
Heart Atria
Heart Failure
Humans
John Wiley and Sons Ltd
Afficher la notice complète
Résumé
[No abstract available]
URI
http://hdl.handle.net/11615/79795
Collections
  • Δημοσιεύσεις σε περιοδικά, συνέδρια, κεφάλαια βιβλίων κλπ. [19735]

Related items

Showing items related by title, author, creator and subject.

  • Thumbnail

    Ranolazine Added to Amiodarone Facilitates Earlier Conversion of Atrial Fibrillation Compared to Amiodarone-Only Therapy 

    Tsanaxidis N., Aidonidis I., Hatziefthimiou A., Daskalopoulou S.S., Giamouzis G., Triposkiadis F., Skoularigis I. (2017)
    Background: Amiodarone (AMIO) is for many years effectively used to control ventricular rate during atrial fibrillation (AF) and to convert it into sinus rhythm. However, due to its delayed onset of action, ranolazine ...
  • Thumbnail

    Incident Atrial Fibrillation in Systemic Sclerosis: The Predictive Role of B-Type Natriuretic Peptide 

    Giallafos, I.; Triposkiadis, F.; Oikonomou, E.; Giamouzis, G.; Aggeli, K.; Konstantopoulou, P.; Kouranos, V.; Mavrikakis, M.; Giallafos, J.; Stefanadis, C.; Sfikakis, P. P. (2014)
    Introduction: Atrial fibrillation (AF) is common in patients with systemic sclerosis (SSc) and is associated with significant morbidity, mortality, and healthcare expenditures. The aim of this study was to prospectively ...
  • Thumbnail

    Ranolazine depresses conduction of rapid atrial depolarizations in a beating rabbit heart model 

    Aidonidis I., Simopoulos V., Stravela S., Dipla K., Stamatiou R., Hatziefthimiou A., Molyvdas P.-A. (2021)
    Purpose: Previous clinical studies have shown that ranolazine (RAN) added to amiodarone (AMIO) might accelerate the termination of recent-onset atrial fibrillation. This study was undertaken to delineate possible mechanisms ...
htmlmap 

 

Parcourir

Tout DSpaceCommunautés & CollectionsPar date de publicationAuteursTitresSujetsCette collectionPar date de publicationAuteursTitresSujets

Mon compte

Ouvrir une sessionS'inscrire
Help Contact
DepositionAboutHelpContactez-nous
Choose LanguageTout DSpace
EnglishΕλληνικά
htmlmap